Dr. King Discusses Lymph Node Resection in Breast Cancer

Tari King, MD, FACS
Published: Wednesday, Dec 13, 2017



Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses lymph node resection in breast cancer.

One of the most feared side effects of breast cancer is lymphedema, says King. Recent data have shown that less surgery spares the morbidity of removing the lymph nodes, without compromising the patients' long-term outcomes.

Data such as these represent the de-escalation of surgical intervention in the treatment of patients with breast cancer, says King.
 
SELECTED
LANGUAGE


Tari King, MD, FACS, chief of Breast Surgery, Dana-Farber Cancer Institute, Brigham Women’s Cancer Center, discusses lymph node resection in breast cancer.

One of the most feared side effects of breast cancer is lymphedema, says King. Recent data have shown that less surgery spares the morbidity of removing the lymph nodes, without compromising the patients' long-term outcomes.

Data such as these represent the de-escalation of surgical intervention in the treatment of patients with breast cancer, says King.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual Paris Breast Cancer Conference™Dec 31, 20181.5
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x